Association of Coagulopathy and Inflammatory Biomarkers with Severity in SARS-CoV-2-Infected Individuals of the Al-Qunfudhah Region of Saudi Arabia

MA Izhari, MAA Hadadi, RA Alharbi, ARA Gosady… - Healthcare, 2024 - mdpi.com
Background: Identifying prognosticators/predictors of COVID-19 severity is the principal
focus for early prediction and effective management of the disease in a time-bound and cost …

Comparison between clinical characteristics and laboratory findings among patients with complicated and noncomplicated SARS‐CoV‐2 infection: A single‐center …

WA Fadda, MA Al‐Batanony… - Immunity …, 2022 - Wiley Online Library
Abstract Background Coronavirus disease 2019 (COVID‐19) infection is considered a
serious highly infectious disease caused by severe acute respiratory syndrome coronavirus …

Blood coagulation, risk factors and associated complications in COVID-19 patients in Saudi Arabia: A retrospective cohort study

HM Al Nafea, MT Al-Qahtani, FH Al Gahtani… - Medicine, 2023 - journals.lww.com
A good understanding of the possible risk factors for coronavirus disease 19 (COVID-19)
severity could help clinicians in identifying patients who need prioritized treatment to prevent …

Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters

BA Alotaibi, JA Aldali, HJ Aldali… - Transactions of The …, 2024 - academic.oup.com
Background The current study is a retrospective study designed to evaluate changes in
complete blood count and coagulation parameters in adult coronavirus disease 2019 …

Haematological indices and coagulation profile as predictors of disease severity and associations with clinical outcome among COVID-19 patients in Lagos, Nigeria

OO Kalejaiye, AB Bolarinwa, LC Amaeshi… - Annals of African …, 2023 - journals.lww.com
Background: This study aims to evaluate the use of haematological indices and coagulation
profiles as possible low-cost predictors of disease severity and their associations with …

Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients

M Alshipli, TA Altaim, AA Oglat, SA Alsenany… - The Journal of Infection …, 2024 - jidc.org
Introduction: Coronavirus 2019 symptoms include coagulopathy and thromboembolic risk.
Using one parameter to diagnose coagulopathy has little predictive value. Objective: This …

[HTML][HTML] An analysis of hematological, coagulation and biochemical markers in COVID-19 disease and their association with clinical severity and mortality: an Indian …

M Pujani, S Raychaudhuri, M Singh… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Background: The “cytokine storm”(CS) in COVID-19 leads to the worst stage of illness which
can be controlled only with timely intervention. There is an urgent need to identify laboratory …

Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital

L Sukrisman, R Sinto - Journal of International Medical …, 2021 - journals.sagepub.com
Background Coagulopathy and inflammation are associated with coronavirus disease 2019
(COVID-19) severity. This study assessed D-dimer concentration and its correlation with …

A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India

GK Bohra, A Purohit, D Kumar, MK Garg… - … Current Drug Targets …, 2021 - ingentaconnect.com
Background: The understanding of pathogenesis is necessary for the development of
effective treatment for COVID-19. Various studies have postulated that there is a complex …

Assessment of COVID-19 associated coagulopathy and multiple hemostatic markers: a single center study in Egypt

A Abdelaal, A Abu-Elfatth, LM Bakkar, HGA El-Azeem… - Infection, 2023 - Springer
Background Coagulopathy is still a serious pattern of coronavirus-19 disease. We aimed to
evaluate COVID-19-associated coagulopathy and multiple hemostatic markers in Egyptian …